$STX

MOSLEY WILLIAM D sold $183K of STX

MOSLEY WILLIAM D (CEO) sold 200 shares of Seagate Technology Holdings plc (STX) at $915.52 ($0.18M total) on 2026-06-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · MOSLEY WILLIAM D
Published Jun 2, 2026, 9:16 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 2, 2026, 9:19 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$STX
Neutral
medium confidence
Mentioned
$STX
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$STXNeutralLow
01

Why it matters

The disclosure updates the insider activity record and can marginally influence short-term sentiment, but it does not indicate a new business development or earnings/guidance change.

02

Market read

A routine 10b5-1 insider sale is typically not a standalone catalyst; expect at most a modest, short-lived sentiment effect.

03

What to watch

Traders may overreact to insider selling; the key differentiator is the 10b5-1 structure and the modest share count (200 shares) versus typical trading liquidity.

Relevance 6/10Novelty 6/10Timing: Filed today (2026-06-02) disclosing a 2026-06-01 sale.

Background

SEC Form 4 insider transaction: CEO William D. Mosley reported an open-market sale of 200 STX shares on 2026-06-01, executed under a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$STXNeutralMedium confidence
Context

Seagate CEO William D. Mosley sold $183.1K of STX shares in an open-market transaction under a pre-arranged 10b5-1 plan.

Expected impact

Limited/short-lived impact; any reaction likely fades unless accompanied by other negative company news.

Evidence & confidence

The filing is a routine 10b5-1 sale with small size relative to typical market cap; it provides a datapoint for sentiment rather than a new operational catalyst.

Market effects

Minimal; this is company-specific insider activity with no stated sector-wide catalyst.

Minimal; no geographic or macro linkage stated.

Minimal; no international transaction or guidance change mentioned.

Counterpoint

Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may be mechanically scheduled and not predictive of deteriorating fundamentals.

Key entities

  • Seagate Technology Holdings plc

    Subject of the insider transaction disclosure (STX).

  • William D. Mosley

    CEO who sold 200 STX shares under a pre-arranged 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$NVDAHighAI 9/10

Markets News, Aug. 27, 2026: Nvidia Stock Powers Higher After Earnings, Driving Tech Gains; Nasdaq Closes Sharply Higher

Nvidia (NVDA) reported strong Q2 earnings and raised Q3 revenue guidance to $108B, driving its stock up 9% and boosting tech sector gains. Nasdaq, S&P 500, and Dow closed higher. Other notable movers include Okta (OKTA) +29%, Salesforce (CRM) +23%, and CrowdStrike (CRWD) +20%. Corporate profits surged $400B in Q2, partly due to $71B in tariff refunds.

$STXMed

Moody’s upgrades Seagate Data rating on AI demand strength

Moody's upgraded Seagate Data's corporate family rating to Ba1 from Ba2, citing AI-driven demand for high-capacity HDDs. The agency expects revenues to grow over 30% annually, reaching $20B, and debt to EBITDA to fall below 0.5x. Seagate faces risks from revenue concentration and pricing pressures. The company had $1.7B in cash and access to a $1.3B credit facility as of July 2026.

$MRNAHighAI 8/10

3 Stocks Soared, 3 Stocks Slumped

Moderna (MRNA) surged 176.97% to $174.38 after reporting positive trial results for a cancer therapy with Merck (MRK). Estee Lauder (EL) rose 16% to $98.01 with revenue up 6.5% Y/Y. MicroStrategy (MSTR) gained 12.68% as Bitcoin prices rose. Nebius (NBIS) fell 10% after a $4.5B convertible note offering. Seagate (STX) dropped 8% to $832.56.

$STXMed

REG - Shield Therapeutics - Shield assumes full control of ACCRUFeR® in the US

Shield Therapeutics (STX) will take full control of ACCRUFeR® in the US from Viatris by September 30, 2026. The deal is expected to boost Shield's profitability and growth, with no upfront payments to Viatris. Shield will pay royalties on US net sales, ranging from high single digits to mid-teens over five years, and retain all gross profits from US sales. The transaction is anticipated to enhance Shield's financial profile and support its path to sustained profitability.